Materia Ventures presents its management team and business strategy

• World-class management team with extensive experience in the cannabis and pharmaceutical sectors
• Building a footprint for the manufacture and distribution of medical cannabis and wellness products across the European continent

Toronto, October 29, 2019 - Materia Ventures («Materia» or the «Company»), a medical cannabis and wellness company focused on the European market, is pleased to present its latest news and introduce its management team. The Materia team has decades of collective experience in the fields of cannabis industries, We have a proven expertise in navigating Europe's complex regulatory environment.

Materia is modernizing its manufacturing, extraction and processing facilities in Malta, where the company has received approval for its letter of intent with Malta Enterprises. Materia is about to become one of the first companies to have a GMP-certified functional center in Malta. the European Union (EU) for cannabis in the country, a highly strategic location for exporting products across Europe. The company has also made a strategic investment and joint venture in Denmark, and continues to evaluate opportunities to enter new jurisdictions.

I've been lucky enough to bring together a team of talented, experienced professionals who share the same vision: facilitating access to medical cannabis in Europe», said Deepak Anand, CEO of Materia. «In a short space of time, we have already established a presence in Europe through investments, supply contracts, distribution partnerships and the development of our team. We have also begun construction of our manufacturing and distribution center in Malta, which will position us among the leading players in what we consider to be the largest emerging market in the world. cannabis in the world. We are ready and excited for the future and grateful to have a strong support system of investors, partners and strategic advisors.»

Management team

• Deepak Anand - Chairman and CEO. Mr. Anand has extensive experience in the European pharmaceutical sector, including the supply and distribution of medical cannabis products across Europe. He is considered a thought leader in the cannabis world through his regular interactions with senior government officials, politicians, healthcare professionals, educators, investors, patients and growers. Mr. Anand was previously Vice President of Business Development and Government Relations at Cannabis Compliance Inc. and Vice President of Business Development at Zenabis, a licensed producer of cannabis. Health Canada. Mr. Anand advised the Government of Canada in establishing its policy, regulations and task force on cannabis legalization for recreational purposes. He has also advised other international governments on their cannabis policies. Mr. Anand sits on several non-profit boards in the cannabis sector.
• Nick Pateras - General Manager, Europe. Mr. Pateras has worked in the Fortune 500 healthcare sector, after spending most of his career at Johnson & Johnson overseeing some of the world's leading drug brands and health and beauty products. He gained experience in creating start-ups in the cannabis industry as one of the first employees at Lift & Co. helping to grow the company to over 60 employees, participate in its IPO and secure numerous government contracts. Mr. Pateras enjoys a good reputation in the industry, and has been invited as an industry representative to the cannabis from the Ontario Chamber of Commerce. Previously, he had also designed and taught a course on the fundamentals of the cannabis at George Brown College.
• Dariusz Nieciecki - Chief Financial Officer. Mr. Nieciecki was previously Director of Strategic Initiatives at Brookfield Asset Management, a global alternative asset manager with over US$500 billion in assets under management. At Brookfield, Mr. Nieciecki was heavily involved in the company's strategic and business planning initiatives, as well as several merger and acquisition transactions, including the recent acquisition of Oaktree Capital Holdings. He was also Managing Partner of Red Sky Capital, where he focused on investment strategies in numerous sectors, including healthcare. Mr. Nieciecki held similar responsibilities as Vice President at GMP Investment Management, a multi-strategy hedge fund with a global mandate. Prior to joining GMP, Mr. Nieciecki worked in the mergers and acquisitions groups at Lehman Brothers and Scotia Capital.
• Michael Garbuz - Chairman. Mr. Garbuz is one of the leading entrepreneurs and investors in the cannabis as founder, manager and legal advisor to various private and public cannabis companies worldwide. He has extensive experience in business start-ups, mergers and acquisitions, public offerings, private placements and passing transactions in international markets. Previously, he held the position of legal and corporate strategy advisor at Origin House (formerly CannaRoyalty), and was instrumental in building the company's reputation. cannabis law group Cassels Brock & Blackwell one of Canada's leading cannabis law firms.
• Peter Pottier - Managing Director, United Kingdom. Mr Pottier has over ten years' experience in some of the world's leading pharmaceutical companies. He has held a variety of positions, including finance, strategy and international operations. Mr. Pottier was responsible for business development and strategy for the EU at Pfizer, and held progressively senior positions at PepsiCo, where he focused on operations in Canada, the USA and the UK.
• Dennis Beker - Vice-President, Legal and Corporate Strategy. Mr. Beker has extensive experience in the fields of corporate law, mergers & acquisitions and corporate finance. He has worked with both public and private companies and has been involved in numerous global transactions, including mergers and acquisitions, mergers and acquisitions and corporate finance. takeover bids, He has been involved in a wide range of transactions, including public offerings, debt and equity financings, bank financings, private placements and corporate restructurings. While at Goodmans LLP, he was involved in several major financial agreements for the cannabis industry.
• Greg Gorzkowski - Vice-President, Business Development and Strategy. Mr. Gorzkowski previously worked for Shopify, one of the world's largest online commerce and retail companies, where he helped launch its global cannabis program. He has worked with many of Canada's largest licensed producers, participating in direct sales of medical cannabis to their patients, as well as with Canada's largest provinces for their adult-use cannabis platforms. He then helped create Ample Organics' seed-to-plant tracking platform, which covers 70% of licensed growers in Canada. Mr. Gorzkowski brings a wealth of knowledge on international regulations and the cannabis supply chain.

About Materia Ventures

Materia Ventures' vision is to facilitate access to cannabis worldwide. Materia is building a strong manufacturing and distribution ecosystem to develop the legal cannabis market on the European continent. Thanks to its expertise, research team and cutting-edge technology, Materia focuses on the high-margin downstream activities of processing, formulation and distribution to markets wherever a patient needs. of cannabis-based medicines.

For further information, please contact :

Dennis Fong, Investor Relations
Telephone: 1-416-283-9930
E-mail: [email protected]
Website: http://www.materiaventures.com/

WARNING

All statements other than statements of historical fact contained herein are forward-looking statements. press release are forward-looking statements that are based on expectations, estimates and projections as of the date of this press release. Any statement that involves discussions regarding future expectations, beliefs, plans, projections, objectives, assumptions, events or performance is not a statement of historical fact and may constitute a forward-looking statement. In this press release, forward-looking statements relate to, among other things, the timetable for receiving the completion of the Malta facility and obtaining EU-GMP certification, as well as the anticipated size of the European cannabis market medical. Forward-looking statements are necessarily based on a number of estimates and assumptions which, although considered reasonable, are subject to known and unknown risks, uncertainties and other factors that may cause actual results and future events to differ materially from those expressed or implied by forward-looking statements. These factors include, but are not limited to: general business, economic, competitive, political and legal uncertainties, access to financing, delay or failure to receive regulatory approvals, and other factors. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Materia Ventures assumes no obligation to update statements of belief, opinions, projections or other forward-looking factors, if any.